Bryan Greene is the Co-Chief Executive Officer of Quadrant Laboratories and the Chief Operating Officer of Quadrant Biosciences, a life sciences company dedicated to improving the lives of children and families by delivering innovative diagnostic, therapeutic, and virtual care solutions for global health priorities. . He graduated with distinction from Clarkson University with a BS in Chemical Engineering. He has more than 15 years of experience in medical device operations, manufacturing, validation, and new-product introduction at both large multinational and start-up corporations. Greene has a demonstrated work history in operations and engineering, including successfully introducing Class I, II, and III products at Life Technologies (Thermo Fisher Scientific), Pall Corporation, and ImClone System (Eli Lilly). Prior to joining Quadrant, Bryan was the manufacturing and operations leader during the establishment and implementation of an FDA 21CFR820-compliant system at Rheonix, a medical device start-up.